LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 77

Search options

  1. Article ; Online: Efficacy and safety of full-dose dabrafenib and trametinib combination therapy in a patient on hemodialysis with metastatic melanoma.

    Hayakawa, Kazuma / Wakimoto, Hiroko / Mae, Kenichihro / Irisawa, Ryokichi / Harada, Kazutoshi

    International journal of dermatology

    2020  Volume 60, Issue 4, Page(s) 516–517

    MeSH term(s) Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Humans ; Imidazoles ; Melanoma/drug therapy ; Mutation ; Oximes/adverse effects ; Proto-Oncogene Proteins B-raf/genetics ; Pyridones ; Pyrimidinones ; Renal Dialysis ; Skin Neoplasms/drug therapy
    Chemical Substances Imidazoles ; Oximes ; Pyridones ; Pyrimidinones ; trametinib (33E86K87QN) ; Proto-Oncogene Proteins B-raf (EC 2.7.11.1) ; dabrafenib (QGP4HA4G1B)
    Language English
    Publishing date 2020-11-09
    Publishing country England
    Document type Letter
    ZDB-ID 412254-9
    ISSN 1365-4632 ; 0011-9059 ; 1461-1244
    ISSN (online) 1365-4632
    ISSN 0011-9059 ; 1461-1244
    DOI 10.1111/ijd.15298
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Inhibition of miR-199a-3p in a murine hypertrophic cardiomyopathy (HCM) model attenuates fibrotic remodeling.

    Zalivina, Irina / Barwari, Temo / Yin, Xiaoke / Langley, Sarah R / Barallobre-Barreiro, Javier / Wakimoto, Hiroko / Zampetaki, Anna / Mayr, Manuel / Avkiran, Metin / Eminaga, Seda

    Journal of molecular and cellular cardiology plus

    2023  Volume 6, Page(s) 100056

    Abstract: Background: Hypertrophic cardiomyopathy (HCM) is an autosomal dominant genetic disorder, characterized by cardiomyocyte hypertrophy, cardiomyocyte disarray and fibrosis, which has a prevalence of ∼1: 200-500 and predisposes individuals to heart failure ... ...

    Abstract Background: Hypertrophic cardiomyopathy (HCM) is an autosomal dominant genetic disorder, characterized by cardiomyocyte hypertrophy, cardiomyocyte disarray and fibrosis, which has a prevalence of ∼1: 200-500 and predisposes individuals to heart failure and sudden death. The mechanisms through which diverse HCM-causing mutations cause cardiac dysfunction remain mostly unknown and their identification may reveal new therapeutic avenues. MicroRNAs (miRNAs) have emerged as critical regulators of gene expression and disease phenotype in various pathologies. We explored whether miRNAs could play a role in HCM pathogenesis and offer potential therapeutic targets.
    Methods and results: Using high-throughput miRNA expression profiling and qPCR analysis in two distinct mouse models of HCM, we found that miR-199a-3p expression levels are upregulated in mutant mice compared to age- and treatment-matched wild-type mice. We also found that miR-199a-3p expression is enriched in cardiac non-myocytes compared to cardiomyocytes. When we expressed miR-199a-3p mimic in cultured murine primary cardiac fibroblasts and analyzed the conditioned media by proteomics, we found that several extracellular matrix (ECM) proteins (
    Conclusions: Altogether, our results suggest that miR-199a-3p may contribute to cardiac fibrosis in HCM through its actions in cardiac fibroblasts. Thus, inhibition of miR-199a-3p in mild-to-moderate HCM may offer therapeutic benefit in combination with complementary approaches that target the primary defect in cardiac myocytes.
    Language English
    Publishing date 2023-12-22
    Publishing country Netherlands
    Document type Journal Article
    ISSN 2772-9761
    ISSN (online) 2772-9761
    DOI 10.1016/j.jmccpl.2023.100056
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Photodynamic augmentation of oncolytic virus therapy for central nervous system malignancies.

    Shimizu, Kazuhide / Kahramanian, Andranik / Jabbar, Muzammil Arif Din Abdul / Turna Demir, Fatma / Gokyer, Dilan / Uthamacumaran, Abicumaran / Rajan, Anant / Saad, Mohammad Ahsan / Gorham, Joshua / Wakimoto, Hiroko / Martuza, Robert L / Rabkin, Samuel D / Hasan, Tayyaba / Wakimoto, Hiroaki

    Cancer letters

    2023  Volume 572, Page(s) 216363

    Abstract: Oncolytic viruses (OVs) have emerged as a clinical therapeutic modality potentially effective for cancers that evade conventional therapies, including central nervous system malignancies. Rationally designed combinatorial strategies can augment the ... ...

    Abstract Oncolytic viruses (OVs) have emerged as a clinical therapeutic modality potentially effective for cancers that evade conventional therapies, including central nervous system malignancies. Rationally designed combinatorial strategies can augment the efficacy of OVs by boosting tumor-selective cytotoxicity and modulating the tumor microenvironment (TME). Photodynamic therapy (PDT) of cancer not only mediates direct neoplastic cell death but also primes the TME to sensitize the tumor to secondary therapies, allowing for the combination of two potentially synergistic therapies with broader targets. Here, we created G47Δ-KR, clinical oncolytic herpes simplex virus G47Δ that expresses photosensitizer protein KillerRed (KR). Optical properties and cytotoxic effects of G47Δ-KR infection followed by amber LED illumination (peak wavelength: 585-595 nm) were examined in human glioblastoma (GBM) and malignant meningioma (MM) models in vitro. G47Δ-KR infection of tumor cells mediated KR expression that was activated by LED and produced reactive oxygen species, leading to cell death that was more robust than G47Δ-KR without light. In vivo, we tested photodynamic-oncolytic virus (PD-OV) therapy employing intratumoral injection of G47Δ-KR followed by laser light tumor irradiation (wavelength: 585 nm) in GBM and MM xenografts. PD-OV therapy was feasible in these models and resulted in potent anti-tumor effects that were superior to G47Δ-KR alone (without laser light) or laser light alone. RNA sequencing analysis of post-treatment tumor samples revealed PD-OV therapy-induced increases in TME infiltration of variable immune cell types. This study thus demonstrated the proof-of-concept that G47Δ-KR enables PD-OV therapy for neuro-oncological malignancies and warrants further research to advance potential clinical translation.
    MeSH term(s) Humans ; Oncolytic Virotherapy ; Central Nervous System Neoplasms ; Meningioma ; Oncolytic Viruses/genetics ; Glioblastoma ; Meningeal Neoplasms ; Tumor Microenvironment
    Language English
    Publishing date 2023-08-22
    Publishing country Ireland
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 195674-7
    ISSN 1872-7980 ; 0304-3835
    ISSN (online) 1872-7980
    ISSN 0304-3835
    DOI 10.1016/j.canlet.2023.216363
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Paradoxical adverse events in the oral cavity caused by anti-tumor necrosis factor-α therapy for pustulotic arthro-osteitis.

    Ito, Sonoko / Kato, Yukihiko / Wakimoto, Hiroko / Nishiwaki, Kaoru / Onishi, Kae / Mori, Tasuo / Yokogawa, Naoto

    The Journal of dermatology

    2020  Volume 47, Issue 9, Page(s) e317–e319

    MeSH term(s) Humans ; Mouth ; Osteitis ; Psoriasis
    Language English
    Publishing date 2020-06-25
    Publishing country England
    Document type Letter
    ZDB-ID 800103-0
    ISSN 1346-8138 ; 0385-2407
    ISSN (online) 1346-8138
    ISSN 0385-2407
    DOI 10.1111/1346-8138.15469
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Efficacy of autologous dermal sheath cup cell transplantation in male and female pattern hair loss: A Single-Arm, Multi-Center, phase III equivalent clinical study.

    Harada, Kazutoshi / Ohyama, Manabu / Niiyama, Shiro / Irisawa, Ryokichi / Mae, Kenichiro / Mori, Miho / Wakimoto, Hiroko / Kinoshita-Ise, Misaki / Fukuyama, Masahiro / Hayakawa, Reina / Takagi, Masaya / Yamazaki, Masako / Miyoshi, Mami / Nishikawa, Saori / Sato, Seiji / Nakazawa, Yosuke / Sugimoto, Takaki / Ogo, Masashi / Tsuboi, Ryoji

    The Journal of dermatology

    2023  Volume 50, Issue 12, Page(s) 1539–1549

    Abstract: A previous, proof-of-concept clinical study suggested that dermal sheath cup cell injections into the affected areas of male/female pattern hair loss (PHL) may have some amelioratory effects, the clinical efficacy of which needs further examination. A ... ...

    Abstract A previous, proof-of-concept clinical study suggested that dermal sheath cup cell injections into the affected areas of male/female pattern hair loss (PHL) may have some amelioratory effects, the clinical efficacy of which needs further examination. A phase III equivalent clinical study was conducted to further probe the therapeutic potential of this novel approach and verify its safety and efficacy in improving the appearance of PHL. Thirty-six participants with PHL were injected with dermal sheath cup cell harvested from non-affected occipital hair follicles twice in quarterly intervals. Global photographic assessment and phototrichogram were performed in a blinded manner. Patient-reported outcomes were assessed for 12 months. On global photographic assessment, 30% of the participants showed improvement. The analysis of phototricogram data detected the increases in the cumulative hair diameter, hair cross-sectional area, and mean hair diameter of 107.6 ± 152.6 μm/cm
    MeSH term(s) Female ; Humans ; Male ; Alopecia/surgery ; Cell Transplantation ; Hair ; Hair Follicle ; Treatment Outcome
    Language English
    Publishing date 2023-09-26
    Publishing country England
    Document type Clinical Trial, Phase III ; Journal Article ; Multicenter Study
    ZDB-ID 800103-0
    ISSN 1346-8138 ; 0385-2407
    ISSN (online) 1346-8138
    ISSN 0385-2407
    DOI 10.1111/1346-8138.16957
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Pathogenesis of Cardiomyopathy Caused by Variants in

    Agarwal, Radhika / Wakimoto, Hiroko / Paulo, Joao A / Zhang, Qi / Reichart, Daniel / Toepfer, Christopher / Sharma, Arun / Tai, Angela C / Lun, Mingyue / Gorham, Joshua / DePalma, Steven R / Gygi, Steven P / Seidman, J G / Seidman, Christine E

    Circulation

    2022  Volume 146, Issue 22, Page(s) 1674–1693

    Abstract: Background: ALPK3: Methods: We explored the putative kinase activity of ALPK3 and the consequences of damaging variants using isogenic human induced pluripotent stem cell-derived cardiomyocytes, mice, and human patient tissues.: Results: Multiple ... ...

    Abstract Background: ALPK3
    Methods: We explored the putative kinase activity of ALPK3 and the consequences of damaging variants using isogenic human induced pluripotent stem cell-derived cardiomyocytes, mice, and human patient tissues.
    Results: Multiple sequence alignment of all human α-kinase domains and their orthologs revealed 4 conserved residues that were variant only in ALPK3, demonstrating evolutionary divergence of the ALPK3 α-kinase domain sequence. Phosphoproteomic evaluation of both ALPK3 kinase domain inhibition and overexpression failed to detect significant changes in catalytic activity, establishing ALPK3 as a pseudokinase. Investigations into alternative functions revealed that ALPK3 colocalized with myomesin proteins (MYOM1, MYOM2) at both the nuclear envelope and the sarcomere M-band.
    Conclusions: ALPK3 is an essential cardiac pseudokinase that inserts in the nuclear envelope and the sarcomere M-band. Loss of ALPK3 causes mislocalization of myomesins, critical force-buffering proteins in cardiomyocytes, and also dysregulates M-band proteins necessary for sarcomere protein turnover. We conclude that
    MeSH term(s) Adult ; Animals ; Child ; Humans ; Mice ; Cardiomyopathies/genetics ; Cardiomyopathies/metabolism ; Connectin/metabolism ; Induced Pluripotent Stem Cells/metabolism ; Muscle Proteins/genetics ; Myocytes, Cardiac/metabolism ; Sarcomeres/metabolism ; Protein Kinases/genetics
    Chemical Substances Connectin ; Muscle Proteins ; Alpk3 protein human ; Protein Kinases (EC 2.7.-)
    Language English
    Publishing date 2022-11-02
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 80099-5
    ISSN 1524-4539 ; 0009-7322 ; 0069-4193 ; 0065-8499
    ISSN (online) 1524-4539
    ISSN 0009-7322 ; 0069-4193 ; 0065-8499
    DOI 10.1161/CIRCULATIONAHA.122.059688
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Histone deacetylase inhibitors enhance oncolytic herpes simplex virus therapy for malignant meningioma.

    Kawamura, Yoichiro / Hua, Lingyang / Gurtner, Alessandra / Wong, Ego / Kiyokawa, Juri / Shah, Nadia / Gorham, Joshua / Wakimoto, Hiroko / Rabkin, Samuel D / Martuza, Robert L / Wakimoto, Hiroaki

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

    2022  Volume 155, Page(s) 113843

    Abstract: Approximately 20% of meningiomas are not benign (higher grade) and tend to relapse after surgery and radiation therapy. Malignant (anaplastic) meningioma (MM) is a minor subset of high-grade meningioma that is lethal with no effective treatment options ... ...

    Abstract Approximately 20% of meningiomas are not benign (higher grade) and tend to relapse after surgery and radiation therapy. Malignant (anaplastic) meningioma (MM) is a minor subset of high-grade meningioma that is lethal with no effective treatment options currently. Oncolytic herpes simplex virus (oHSV) is a powerful anti-cancer modality that induces both direct cell death and anti-tumor immunity, and has shown activity in preclinical models of MM. However, clinically meaningful efficacy will likely entail rational mechanistic combination approaches. We here show that epigenome modulator histone deacetylase inhibitors (HDACi) increase anti-cancer effects of oHSV in human MM models, IOMM-Lee (NF2 wild-type) and CH157 (NF2 mutant). Minimally toxic, sub-micromolar concentrations of pan-HDACi, Trichostatin A and Panobinostat, substantively increased the infectability and spread of oHSV G47Δ within MM cells in vitro, resulting in enhanced oHSV-mediated killing of target cells when infected at low multiplicity of infection (MOI). Transcriptomics analysis identified selective alteration of mRNA processing and splicing modules that might underlie the potent anti-MM effects of combining HDACi and oHSV. In vivo, HDACi treatment increased intratumoral oHSV replication and boosted the capacity of oHSV to control the growth of human MM xenografts. Thus, our work supports further translational development of the combination approach employing HDACi and oHSV for the treatment of MM.
    MeSH term(s) Humans ; Meningioma/drug therapy ; Histone Deacetylase Inhibitors/pharmacology ; Histone Deacetylase Inhibitors/therapeutic use ; Panobinostat ; Neoplasm Recurrence, Local ; Simplexvirus/genetics ; Herpes Simplex ; Meningeal Neoplasms ; RNA, Messenger
    Chemical Substances Histone Deacetylase Inhibitors ; Panobinostat (9647FM7Y3Z) ; RNA, Messenger
    Language English
    Publishing date 2022-10-08
    Publishing country France
    Document type Journal Article
    ZDB-ID 392415-4
    ISSN 1950-6007 ; 0753-3322 ; 0300-0893
    ISSN (online) 1950-6007
    ISSN 0753-3322 ; 0300-0893
    DOI 10.1016/j.biopha.2022.113843
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: AAV9 Delivery of shRNA to the Mouse Heart.

    Wakimoto, Hiroko / Seidman, J G / Foo, Roger S Y / Jiang, Jianming

    Current protocols in molecular biology

    2016  Volume 115, Page(s) 23.16.1–23.16.9

    Abstract: RNA interference (RNAi) is a rapid approach to dissect loss-of-function phenotype for a gene of interest. However, it is challenging to perform RNAi in specific organs and tissues in vivo. Engineered viruses can provide a useful tool for delivery of ... ...

    Abstract RNA interference (RNAi) is a rapid approach to dissect loss-of-function phenotype for a gene of interest. However, it is challenging to perform RNAi in specific organs and tissues in vivo. Engineered viruses can provide a useful tool for delivery of small RNAs in vivo. Recombinant adeno-associated viruses (rAAVs) are the preferred method for delivering genes or gene modulators to target cells due to their high titer, low immune response, ability to transduce many types of cell, and overall safety. In this unit, we describe protocols for use of rAAVs as a cargo to deliver miRNA backbone-based shRNA controlled by a cardiac-specific promoter into the mouse heart. © 2016 by John Wiley & Sons, Inc.
    MeSH term(s) Animals ; Dependovirus/genetics ; Gene Transfer Techniques ; Genetic Engineering ; HEK293 Cells ; Humans ; Mice ; Myocardium/metabolism ; RNA Interference ; RNA, Small Interfering/administration & dosage ; RNA, Small Interfering/genetics ; Transduction, Genetic
    Chemical Substances RNA, Small Interfering
    Language English
    Publishing date 2016-07-01
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ISSN 1934-3647
    ISSN (online) 1934-3647
    DOI 10.1002/cpmb.9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Isolation of single-stranded DNA.

    Wakimoto, Yuji / Jiang, Jianming / Wakimoto, Hiroko

    Current protocols in molecular biology

    2014  Volume 107, Page(s) 2.15.1–9

    Abstract: Single-stranded DNA (ssDNA) is often used for DNA sequencing as well as microarray and hybridization technologies. Asymmetric PCR or exonuclease digestion followed by urea gel separation and isolation on streptavidin-coated magnetic beads are commonly ... ...

    Abstract Single-stranded DNA (ssDNA) is often used for DNA sequencing as well as microarray and hybridization technologies. Asymmetric PCR or exonuclease digestion followed by urea gel separation and isolation on streptavidin-coated magnetic beads are commonly used for this purpose. These two methods may not yield large amounts of highly purified ssDNA. This protocol for ssDNA isolation from PCR-amplified DNA involves biotin labeling of one strand and subsequent strand separation utilizing streptavidin-coated magnetic beads.
    MeSH term(s) DNA, Single-Stranded/chemistry ; DNA, Single-Stranded/isolation & purification ; Magnetic Fields ; Polymerase Chain Reaction/methods ; Streptavidin/chemistry
    Chemical Substances DNA, Single-Stranded ; Streptavidin (9013-20-1)
    Language English
    Publishing date 2014-07-01
    Publishing country United States
    Document type Journal Article
    ISSN 1934-3647
    ISSN (online) 1934-3647
    DOI 10.1002/0471142727.mb0215s107
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Cardiomyocyte Proliferative Capacity Is Restricted in Mice With

    Onoue, Kenji / Wakimoto, Hiroko / Jiang, Jiangming / Parfenov, Michael / DePalma, Steven / Conner, David / Gorham, Joshua / McKean, David / Seidman, Jonathan G / Seidman, Christine E / Saito, Yoshihiko

    Frontiers in cardiovascular medicine

    2021  Volume 8, Page(s) 639148

    Abstract: ... ...

    Abstract LMNA
    Language English
    Publishing date 2021-06-23
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2781496-8
    ISSN 2297-055X
    ISSN 2297-055X
    DOI 10.3389/fcvm.2021.639148
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top